Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-08-07
1986-08-19
Brust, Joseph Paul
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548567, A61K 3140, C07D20709
Patent
active
046070478
ABSTRACT:
N-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy-4-amino-5-methylsulphamoyl benzamide and its pharmacologically acceptable salts thereof are taught to be useful in treating a subject suffering from platelet dysfunction in thrombo-embolic disorders.
REFERENCES:
patent: 4263316 (1981-04-01), Thominet et al.
patent: 4294828 (1981-10-01), Thominet et al.
patent: 4351770 (1982-09-01), Ogata et al.
patent: 4405636 (1983-09-01), Perrot et al.
patent: 4499019 (1985-02-01), Thominet et al.
Evans, et al.; J. Exp. Med.; 128: 877-894 (1968).
Mustard, et al.; J. Lab. Clin. Med.; 64: pp. 548-558 (1964).
Brust Joseph Paul
Societe d'Etudes Scientifiques et Industrielles de l'Ile-De-Fran
LandOfFree
N-(allyl-2-pyrrolidinylmethyl) 2-methoxy-4-amino-5-methylsulfamo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(allyl-2-pyrrolidinylmethyl) 2-methoxy-4-amino-5-methylsulfamo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(allyl-2-pyrrolidinylmethyl) 2-methoxy-4-amino-5-methylsulfamo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-394198